 |
|
|
|
|
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
Contact:
Beth Frost-Johnson, Sr. VP of Marketing
Merge Healthcare
(414) 977-4254
bethfj@merge.com
|
|
Rich Linden, President & CEO
Merge Healthcare
(414) 977-4000
rlinden@merge.com
|
|
MERGE EMED TO SHOWCASE INNOVATIVE SOFTWARE SOLUTIONS AT
THE 2006 HEALTHCARE INFORMATION AND MANAGEMENT SYSTEMS
SOCIETY (HIMSS)
Merge eMed to demonstrate RIS, PACS, and RIS/PACS Solutions
Milwaukee, WI, February 2, 2006 – Merge eMed, a Merge Healthcare company and a leader in healthcare software and services, today announced that it will showcase a variety of innovative software solutions at the 2006 Healthcare Information and Management Systems Society (HIMSS) conference held February 12-16 in San Diego, CA.
“HIMSS marks an excellent opportunity for us to showcase the comprehensive image and
information management capabilities of Merge eMed,” said David Noshay, President - Merge
eMed. “Merge eMed’s powerful end-user RIS, PACS, RIS/PACS, advanced visualization and
clinical applications offer our customers flexible and innovative digital workflow solutions."
"Merge eMed offers one of the most comprehensive product portfolios for the integration of
business and clinical workflow," said Dave Mahoney, Vice-President of Sales - Merge eMed. "We are unmatched in our ability to provide RIS, PACS, RIS/PACS, advanced visualization and clinical applications, all from a single, trusted partner."
More healthcare CIO's than ever are tasked with enterprise-wide medical imaging workflow, along with its integration with other workflow applications throughout the healthcare organization. As medical imaging grows in its capabilities and complexities and moves into specialties beyond radiology, the importance of advanced visualization and clinical applications combined with the efficiencies of managing workflow with an integrated RIS/PACS become paramount to the healthcare organization's overall productivity. Merge eMed offers those solutions, backed by more than twenty years of Healthcare Information Technology integration expertise.
Merge eMed is located at HIMSS booth 7601. For further information, or to schedule a demonstration at HIMSS, visit www.merge-emed.com.
For further information, please contact:
Beth Frost-Johnson, Sr. VP of Marketing
Merge Healthcare
(414) 977-4254
bethfj@merge-emed.com
# # #
Merge Healthcare is a market leader in the development and delivery of medical imaging and information management software and services. Our innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve our customers' productivity and enhance the quality of patient care they provide. For additional information, visit our website at www.mergehealtcare.com.
Merge eMed, a Merge Healthcare company,is focused on accelerating productivity for radiology departments and specialty practices, imaging centers and hospitals. By combining sophisticated RIS, PACS, advanced visualization and clinical imaging applications, Merge eMed delivers integrated end-to-end software solutions and professional services that are transforming the way our customers interact with referring physicians, manage their workflow, position their businesses in their markets and deliver imaging and information services to their customers. For additional information, visit our website at www.merge-emed.com.
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
